Home/Vor Biopharma/Navid Z. Khan, PhD
NZ

Navid Z. Khan, PhD

Chief Medical Affairs Officer

Vor Biopharma

Vor Biopharma Pipeline

DrugIndicationPhase
TelitaciceptMyasthenia Gravis (MG)Phase 3